Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
, we also aim to obtain the first structures of CuNiR-qNOR protein-protein complexes in catalytic turnover. We require an experienced PDRA with fluency in several elements of a structural biology project
-
of Systems, Molecular & Integrative Biology (ISMIB), University of Liverpool, UK. ISMIB offers a number of high-quality shared facilities, which will be used to complete the project. You will interact and
-
have the knowledge and practical experience in one or more of the biological subject areas (eg. Biological Sciences, Pharmacology, Biochemistry, Microbiology, Molecular Biology). We offer a generous
-
to this post (e.g. cell biology, physiology, ophthalmology, and related). This post is available 3 March 2027. Any applicants who are still awaiting their PhD to be awarded should be aware that if successful
-
investigate the potential of targeting senescent cells within the choriocapillaris to stop the progression of dry AMD. We will expand the scientific knowledge surrounding the molecular biology of cell ageing
-
This is an exciting opportunity to join a research group working at the frontiers of cell ageing. This full-time Technical post funded by the Leverhulme Trust will investigate new biology
-
to try to solve the 3D structure of histone H4-fibrinogen microclots. You will have a PhD in Biochemistry or related discipline. Laboratory experience with protein biochemistry, structural biology, EM
-
Vaccines through Sequencing and Antigenic Cartography¿. The successful candidate will have practical cell culture and molecular biology experience to aid the provision of an effective and efficient technical
-
discipline with expertise in cell biology, and evidence of a productive research career. Experience in relevant models, flow cytometry, histology and/or bioinformatics is desirable. Informal enquiries: Dr Joe
-
This is an exciting opportunity to join a research group working at the frontiers of vascular ageing. This full-time PDRA funded by the Leverhulme Trust will uncover new biology by investigating a